cepia

Clinical Epidemiology and Ageing

Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.

Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F Leuk Lymphoma. 2021;62(4):979-983.
MeSH terms: Amyloidosis; Antibodies, Monoclonal; Humans
DOI: 10.1080/10428194.2020.1850717
PubMed Google Scholar